Cargando…

DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT Pathway

Esophageal cancer (ESC) is one of the most deadly diseases for human. p53 in most cancers, including ESC cell, is mutated, and the mutated p53 losses its original function and acquires “gain of function” that allows for promoting the hallmarks of cancer, such as antiapoptosis, metastasis, invasion,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhuo, Li, Cuiping, Li, Yongli, Guo, Xingshuang, Yan, Zhaoyu, Gao, Fulian, Li, Changzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636558/ https://www.ncbi.nlm.nih.gov/pubmed/31354907 http://dx.doi.org/10.1155/2019/5414670

Ejemplares similares

Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy
por: Guo, Xingshuang, et al.
Publicado: (2018)

p53-Mediated PI3K/AKT/mTOR Pathway Played a Role in Ptox(Dpt)-Induced EMT Inhibition in Liver Cancer Cell Lines
por: Li, Yongli, et al.
Publicado: (2019)

DpdtC-Induced EMT Inhibition in MGC-803 Cells Was Partly through Ferritinophagy-Mediated ROS/p53 Pathway
por: Feng, Jiankang, et al.
Publicado: (2020)

Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway
por: Li, Yongli, et al.
Publicado: (2019)

Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation
por: Huang, Tengfei, et al.
Publicado: (2018)

Ferritinophagic Flux Activation in CT26 Cells Contributed to EMT Inhibition Induced by a Novel Iron Chelator, DpdtpA
por: Sun, Yanjie, et al.
Publicado: (2019)

TNK2 promoted esophageal cancer progression via activating egfr‐akt signaling
por: Zhang, Anqing, et al.
Publicado: (2021)

Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway
por: Gu, Jiajia, et al.
Publicado: (2016)

A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells
por: Yang, Yun, et al.
Publicado: (2020)

Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis
por: Shan, Zheng-Zheng, et al.
Publicado: (2017)

Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes
por: Lehman, Heather L., et al.
Publicado: (2020)

Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth
por: Allahverdi, Amir, et al.
Publicado: (2020)

Induction of Apoptosis by Luteolin Involving Akt Inactivation in Human 786-O Renal Cell Carcinoma Cells
por: Ou, Yen-Chuan, et al.
Publicado: (2013)

[6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
por: Jiang, Xueyi, et al.
Publicado: (2021)

Skewed X-chromosome inactivation in patients with esophageal carcinoma
por: Li, Gang, et al.
Publicado: (2013)

Involvement of Glutathione Depletion in Selective Cytotoxicity of Oridonin to p53-Mutant Esophageal Squamous Carcinoma Cells
por: Li, Yinchao, et al.
Publicado: (2020)

Stretching magnitude–dependent inactivation of AKT by ROS led to enhanced p53 mitochondrial translocation and myoblast apoptosis
por: Song, Jing, et al.
Publicado: (2019)

D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy
por: Barra, Jonathan, et al.
Publicado: (2021)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
por: Ding, Jie, et al.
Publicado: (2022)

Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
por: Dahle-Smith, Åsa, et al.
Publicado: (2015)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

HPV infection and p53 inactivation in pterygium
por: Tsai, Yi-Yu, et al.
Publicado: (2009)

Long Noncoding RNA LINC01485 Promotes Tumor Growth and Migration via Inhibiting EGFR Ubiquitination and Activating EGFR/Akt Signaling in Gastric Cancer
por: Zhou, Jianping, et al.
Publicado: (2020)

Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells
por: Zang, Yunjin, et al.
Publicado: (2017)

Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation
por: Li, Wei, et al.
Publicado: (2018)

Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS
por: He, Feng, et al.
Publicado: (2016)

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma
por: Alexandru, Oana, et al.
Publicado: (2018)

Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012)

Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
por: Li, Bin, et al.
Publicado: (2014)

Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer
por: Yu, Xinyou, et al.
Publicado: (2020)

Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt
por: Suprynowicz, Frank A., et al.
Publicado: (2017)

Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
por: Cheng, Dong-Dong, et al.
Publicado: (2017)

Cas9 activates the p53 pathway and selects for p53-inactivating mutations
por: Enache, Oana M., et al.
Publicado: (2020)

LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway
por: Li, Yansheng, et al.
Publicado: (2019)

Ferritinophagy-Mediated Ferroptosis and Activation of Keap1/Nrf2/HO-1 Pathway Were Conducive to EMT Inhibition of Gastric Cancer Cells in Action of 2,2′-Di-pyridineketone Hydrazone Dithiocarbamate Butyric Acid Ester
por: Guan, Deng, et al.
Publicado: (2022)

Spontaneous inactivating p53 mutations and the “selfish cell”
por: Sorscher, Steven M., et al.
Publicado: (2011)

High-SETD8 inactivates p53 in neuroblastoma
por: Veschi, Veronica, et al.
Publicado: (2017)

Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway
por: Li, Zhuo, et al.
Publicado: (2023)

ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
por: Wen, Chuangyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6n32m2m0gl7vldd4rure9gv8cm